Billable Medical Code for Malignant Neoplasm of Prostate
Diagnosis Code for Reimbursement Claim: ICD-9-CM 185
Code will be replaced by October 2015 and relabeled as ICD-10-CM 185.
The Short Description Is: Malign neopl prostate.
Metastatic prostate cancer is also known as adenocarcinoma of prostate, adenocarcinoma, prostate, CA of prostate, CA prostate adenoca, CA prostate primary, cancer of prostate with metastasis to eye, cancer of the prostate, cancer of the prostate with metastasis, cancer of the prostate adenocarcinoma, cancer of the prostate primary, cancer of prostate hormone refractory, carcinoma of prostate, hormone refractory prostate cancer, metastasis from malignant tumor of prostate, metastatic prostate cancer, primary malignant neoplasm of prostate, prostate cancer, prostate cancer metastatic to eye, and prostate cancer hormone refractory. This excludes seminal vesicles (187.8).
Metastatic Prostate Cancer Definition and Symptoms
Metastatic prostate cancer is an advanced form a cancer originating in the prostate. The term metastatic refers to the cancer spreading to any other part of the body from the prostate. The most common places for prostate cancer to spread is in the bones, tissues, and blood. Symptoms of metastatic prostate cancer are pain in the lower back, blood in the urine or semen, trouble urinating, erectile dysfunction, bone pain, and a decreased stream force when urinating. Other symptoms may accompany depending on what part of the body the cancer spread to.